Aktive farmasøytiske ingredienser
Gestagen og østrogen | |||
Produktnavn | Spesifikasjon | Godkjent | CAS-nr. |
Progesteron | CP/EP/USP | CEP/EU-GMP/FDA | 57-83-0 |
Medroksyprogesteronacetat | CP/EP/USP | DMF/GMP | 71-58-9 |
Megestrolacetat | CP/EP/USP | DMF under Arkivering | 595-33-5 |
Mifepriston | CP/IP | DMF/GMP | 84371-65-3 |
Cyproteronacetat | CP/EP | CEP/TGA/GMP | 427-51-0 |
Levonorgestrel | CP/EP/USP | DMF/GMP/CEpin-prosess | 797-63-7 |
Drospirenon | EP/USP | DMF under Arkivering | 67392-87-4 |
Gestodene | CP/EP | DMF/GMP | 60282-87-3 |
Østradiol | CP/EP/USP | DMF | 50-28-2 |
Estriol | CP/EP/USP | Under FoU | 50-27-1 |
Etinylestradiol | CP/EP/USP | DMF/GMP | 57-63-6 |
Østradiolvalerat | CP | DMF under Arkivering | 979-32-8 |
Tibolone | CP/EP | DMF | 5630-53-5 |
Dienogest | EP | DMF under Arkivering | 65928-58-7 |
Fulvestrant | EP/USP | Under FoU | 129453-61-8 |
Androgen | |||
Produktnavn | Spesifikasjon | Godkjent | CAS-nr. |
Finasteride | CP/EP/USP | CEP/FDA/PMDA/GMP | 98319-26-7 |
Dutasteride | EP/USP | CEP/DMF | 164656-23-9 |
Abirateronacetat | CP/USP | DMF | 154229-18-2 |
Testosteron | CP/EP/USP | DMF/CEP i prosess | 58-22-0 |
Testosteron undekanoat | CP | DMF under Arkivering | 5949-44-0 |
Testosteron Cypionate | USP | DMF under Arkivering | 58-20-8 |
DHEA (prasteron) | FP/In-house | DMF/WC/Kosher | 53-43-0 |
Kortikalt hormon | |||
Produktnavn | Spesifikasjon | Godkjent | CAS-nr. |
Budesonid | CP/EP/USP | CEP/FDA/GMP | 51333-22-3 |
Desonid | USP | DMF | 638-94-8 |
Eplerenon | EP | CEP/FDA | 107724-20-9 |
Metylprednisolon | CP/EP/USP | DMF/WC | 83-43-2 |
Metylprednisolon Hemisuccinat | CP/EP/USP | DMF/WC | 2921-57-5 |
Flutikasonpropionat | CP/EP/USP | DMF | 80474-14-2 |
Flutikasonfuroat | In-house | Under FoU | 397864-44-7 |
Mometasonfuroat | CP/EP/USP | Under FoU | 83919-23-7 |
Andre | |||
Produktnavn | Spesifikasjon | Godkjent | CAS-nr. |
Okskarbazepin | CP/EP/USP | CEP/DMF/GMP | 28721-07-5 |
Eslikarbazepinacetat | In-house | DMF under Arkivering | 236395-14-5 |
Ganciclovir | CP/EP/USP | DMF/GMP | 82410-32-0 |
Valganciklovirhydroklorid | USP | DMF under Arkivering | 175865-59-5 |
Oseltamivirfosfat | CP/EP/USP | DMF | 204255-11-8 |
Nintedanib Esylate | In-house | DMF | 656247-18-6 |
Revefenacin | In-house | DMF i prosess | 864750-70-9 |
Mirabegron | In-house | DMF i prosess | 223673-61-8 |
Cariprazin Hydrochloride | In-house | DMF i prosess | 1083076-69-0 |
Lasmiditansuccinat | In-house | DMF i prosess | 439239-92-6 |
Lulikonazol | In-house | DMF i prosess | 187164-19-8 |
Produktnavn | Spesifikasjon | Godkjent | CAS-nr. |
16α-Hydroksyprednisolon | Min 99,0 % | DMF | 13951-70-7 |
16α-Hydroksyprednisolonacetat | Min 98,0 % | DMF | 86401-80-1 |
21-acetoksy-11β-hydroksypregna-1,4,16-trien-3,20-dion | Min 98,0 % | TP | 3044-42-6 |
DHEA (prasterone) | Min 99,0 % | DMF/WC | 53-43-0 |
DHEA-acetat (prasteronacetat) | Min 99,0 % | DMF | 853-23-6 |
Epiandrosteron | Min 99,0 % | TP | 481-29-8 |
Abiraterone | I huset | DMF | 154229-19-3 |
Triacetyl-ganciklovir | Min 98,5 % | TP | 86357-14-4 |
Mono-acetyl ganciclovir | Min 97 % | TP | 194254-40-0 |
16-dehydropregnenolonacetat ï¼16-DPAï¼ | Min 99,0 % | TP | 979-02-2 |
Pregnenolonacetat | Min 98,0 % | TP/ Kosher | 1778-02-5 |
Pregnenolon | Min 99,0 % | TP/Kosher | 145-13-1 |
3-okso-4-androsten-17β-karboksylsyre | Min 99,0 % | TP | 302-97-6 |
4-aza-5α-androstan-3-okso-17β-karboksylsyre | Min 98,0 % | DMF | 103335-55-3 |
4-aza-5α-androstan-1-en-3-okso-17β-karboksylsyre | Min 98,0 % | DMF | 104239-97-6 |
N-tert-butyl-3-okso-4-aza-5α-androst-17β-karboksamid | Min 98,0 % | DMF | 98319-24-5 |
6-klor-1α-klormetyl-3,20-diokso-pregna-4,6-dien-17α-acetoksy | Min 98,0 % | DMF | 17183-98-1 |
Estron | USP36 | TP | 53-16-7 |
Flumetason | Min 98,0 % | TP | 2135-17-3 |